KT&G (033780) Investor Day 2025 Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Day 2025 Presentation summary
23 Sep, 2025Global growth and leadership journey
Achieved strong global CC revenue growth with a 2020-23 CAGR of 4.7% and a 2024 vs. prior year increase of 28.1%.
Operating profit for global CC rebounded by 60.6% in 2024 vs. prior year and is projected to rise 127.8% in 2025 H1 vs. 2024 H1.
Shifted to a global-oriented structure, with global manufacturing and local procurement ratios expected to rise significantly by 2025.
Outperformed KOSPI with a 57.4% increase in stock price and maintained top-tier global credit ratings (S&P A3, Moody's A-, AAA from domestic agencies).
2025 outlook targets double-digit operating profit growth and surpassing KRW 6 trillion in revenue.
Driving shareholder value
Capital allocation strategy redefined to prioritize ROE and ROIC above cost of equity, balancing growth and returns.
Dividend per share (DPS) set to increase to KRW 6,000 for FY 2025, a 300% increment over the previous year.
Total shareholder return ratio projected at over 100% of net income, with significant share buybacks and treasury share cancellations.
Cash return of KRW 3.7 trillion+ planned for 2024-2027, with a payout ratio above 50% and flexible buyback timing.
Strong cash flow and stable debt ratio below 60% support enhanced shareholder returns.
New collaboration for the next growth
Entered a global collaboration with Altria for joint acquisition and expansion in the nicotine pouch market.
Secured leading market positions in Nordic countries and outlined plans for global expansion in Europe, Middle East, South Asia, and APAC.
Latest events from KT&G
- Record FY24 results with global growth, higher dividends, and aggressive buybacks.033780
Q4 202424 Jun 2026 - Q2 profit jumped on global tobacco gains, but 2024 outlook was cut as HFF and real estate lagged.033780
Q2 202424 Jun 2026 - Record tobacco growth and shareholder returns offset declines in net income and real estate.033780
Q3 202424 Jun 2026 - Q1 2025 revenue up 15.4% YoY, strong profit growth, and ongoing share buybacks.033780
Q1 202524 Jun 2026 - Record revenue and operating profit growth, but net income fell; dividends and buybacks increased.033780
Q2 202524 Jun 2026 - Record revenue and profit, net income up 73.4%, guidance raised, global expansion planned.033780
Q3 202524 Jun 2026 - Record Q1 revenue and profit growth driven by global tobacco and health foods, with stronger dividends ahead.033780
Q1 202622 Jun 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026